California CRE News In Your Inbox.
Sign up for Connect emails to stay informed with CRE stories that are 150 words or less.
Bayer Opens $250M Cell Therapy Facility in Berkeley
Fluor Corporation said Thursday it had completed construction of Bayer AG’s $250-million global Cell Therapy Launch Facility, part of the life science giant’s biotechnology campus in Berkeley. Bayer has invested about $500 million in the 46-acre campus over the past five years.
“This new facility ensures our investment in cell therapies can become a reality for patients around the world,” said Stefan Oelrich, president of Bayer’s Pharmaceuticals Division. “Cell therapies represent an important opportunity to treat diseases differently by targeting the underlying cause or enabling the human body to restore vital functions.”
The new biopharmaceutical development and manufacturing facility will be used to produce cell therapies for neurological degenerative disorders, cardiovascular disease and other unmet medical needs.
Richard Meserole, president of Fluor’s Advanced Technologies & Life Sciences business line, said, “The project was phased to allow start-up activities to commence as needed to support production timeline.”
- ◦Development
